C07D 501/52
With the 7-amino radical acylated by an araliphatic carboxylic acid
Official title: with the 7-amino radical acylated by an araliphatic carboxylic acid
C07D501/52 (With the 7-amino radical acylated by an araliphatic carboxylic acid) appears on 5 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 5
- Published applications
- 5
- Assignees
- 4
- Inventors
- 11
- Latest grant
- 24 Oct 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 2 | 0 |
| 2018 | 0 | 3 |
| 2019 | 1 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year.
Recent patents
- Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same24 Oct 2023US 11,795,491 B2The General Hospital Corporation
- Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same14 Jan 2020US 10,533,018 B2Duke University
- 2,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosis9 Jul 2019US 10,344,165 B2The Board of Trustees of the Leland Stanford Junior University
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis5 Dec 2017US 9,834,681 B2The Board of Trustees of the Leland Stanford Junior University
- Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same28 Nov 2017US 9,828,622 B2The General Hospital Corporation
- Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same12 Jul 2018US 2018/0194778 A1Duke University
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis5 Apr 2018US 2018/0094139 A1The Board of Trustees of the Leland Stanford Junior University
- Photoactivatable Antimicrobial Agents And Therapeutic And Diagnostic Methods Of Using Same5 Apr 2018US 2018/0094292 A1The General Hospital Corporation
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis6 Aug 2015US 2015/0219653 A1The Board of Trustees of the Leland Stanford Junior University
- Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same12 May 2011US 2011/0112059 A1The General Hospital Corporation
Most cited
By later US patents
- Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same5US 9,828,622 B2The General Hospital Corporation · 2017
- 2,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosis4US 9,834,681 B2The Board of Trustees of the Leland Stanford Junior University · 2017